Diagnostyka i leczenie zatorowości płucnej w okresie ciąży w aspekcie żylnej choroby zakrzepowo-zatorowej

• Authors: Justyna Jarnot , Andrzej Madej , Ilona Kuczerawy , Magdalena Franc

Title variants

EN

Diagnosis and treatment of pulmonary embolism in pregnancy, as a part of venous thromboembolism

• Languages of publication: PL

Abstracts

PL

Zatorowość płucna (ZP) jest częstą przyczyna zgonów kobiet w okresie ciąży i połogu. W związku z fizjologicznymi zmianami u kobiet ciężarnych wzrasta ryzyko powikłań zakrzepowo-zatorowych. Diagnostyka ZP w tym okresie jest trudna ze względu na niespecyficzne objawy i fizjologiczny wzrost stężenia D-dimerów. W diagnostyce stosuje się badanie ultrasonograficzne układu żylnego oraz badania wykorzystujące promieniowanie jonizujące, jak tomografia komputerowa i scyntygrafia. Obrazowanie jest bezpieczne dla płodu i powinno być stosowane u pacjentek z niespecyficznymi objawami, mogącymi sugerować ZP. Podstawowe miejsce w leczeniu ZP mają heparyny drobnocząsteczkowe (low molecular weight heparins – LMWH).

EN

Pulmonary embolism is a common cause of death among pregnant woman. Physiological changes during pregnancy lead to a higher risk of thromboembolism development. Pulmonary embolism diagnostics is difficult because of its non-specific symptoms and physiological elevated D-dimers concentration. In most cases, venous ultrasonography and examinations with the use of ionized radiation – computer tomography or scintigraphy are usually applied. Imaging is safe and should be performed on all women presenting non-specific chest symptoms during pregnancy. In the treatment of pulmonary embolism, low molecular weight heparins (LMWH) are used.

Keywords

EN

ciąża; delivery; diagnosis; diagnostyka; leczeniepulmonary embolism; poród; pregnancy; treatment; zatorowość płucna

Discipline

• MEDICINE: MEDICINE

• Publisher: Śląski Uniwersytet Medyczny w Katowicach
• Journal: Annales Academiae Medicae Silesiensis
• Year: 2013
• Volume: 67
• Issue: 3
• Pages: 194–200

Contributors

author

Justyna Jarnot

• Studium Doktoranckie Wydziału Lekarskiego w Katowicach Śląskiego Uniwersytetu Medycznego w Katowicach ul. Medyków 12 40-752 Katowice tel. [phone]

author

Andrzej Madej

• Zakład Profilaktyki Chorób Kobiecych i Seksuologii Katedry Zdrowia Kobiety Wydziału Nauk o Zdrowiu Śląskiego Uniwersytetu Medycznego w Katowicach Oddział Chorób Wewnętrznych z Pododdziałem Diagnostyki Kardiologicznej Szpitala Zakonu Bonifratrów w Katowicach

author

Ilona Kuczerawy

• Studium Doktoranckie Wydziału Lekarskiego w Katowicach

author

Magdalena Franc

• Studium Doktoranckie Wydziału Lekarskiego w Katowicach

References

• 1. Heit J., Kobbervig C., James A. i wsp. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann. Intern. Med. 2005; 143: 697–706.
• 2. James A.H., Jamison M.G., Brancazio L.R., Myers E.R. Venous throm-boembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am. J. Obstet. Gynecol. 2006; 194: 1311–1315.
• 3. Simpson E.L., Lawrenson R.A., Nightingale A.L., Farmer R.D. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG 2001; 108: 56–60.
• 4. Blanco-Molina A., Rota L.L., Di Micco P. i wsp. Venous thromboembo-lism during pregnancy, postpartum or duringcontraceptive use. RIETE Investigators. Thromb. Haemost. 2010; 103: 306–311.
• 5. James A., Jamison M., Brancazio L. i wsp. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am. J. Obstet. Gynecol. 2006; 194: 1311–1315.
• 6. Marik P., Plante L. Venous thromboembolic disease and pregnancy. N. Engl. J. Med. 2008; 359: 2025–2033.
• 7. Duhl A.J., Paidas M.J., Ural S.H. i wsp. Antithrombotic therapy and pregnancy: Consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am. J. Obstet. Gynecol. 2007; 197: 457.e1-457.e21.
• 8. Kobayashi T., Nakabayashi M., Ishikawa M. i wsp. Pulmonary thrombo-embolism in obstetrics and gynecology increased by 6.5-fold over the past decade in Japan. Circ. J. 2008; 72: 753–756.
• 9. Kjellberg U., Andersson N.E., Rosen S. i wsp. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb. Haemost. 1999; 81: 527–531.
• 10. Pomp E.R., Lenselink A.M., Rosendaal F.R. i wsp. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J. Thromb. Haemost. 2008; 6: 632–637.
• 11. Eichinger S., Weltermann A., Philipp K. i wsp. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost. 1999; 82: 1232–1236.
• 12. Nelson-Piercy C. Thromboembolic disease in pregnancy. Handbook of obstetric medicine. 4th ed. New York: Informa Healthcare 2010: 90–92
• 13. Macklon N.S., Greer I.A. & Bowman A.W. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. BJOG 1997; 104: 191–197.
• 14. Macklon N., Greer I. The deep venous system in the puerperium: an ultrasound study. Br. J. Obstet. Gynaecol. 1997; 104: 198–200.
• 15. Royal College of Obstetricians and Gynaecologists. Thromboprophylaxis during pregnancy, labour and after vaginal delivery. Guideline 2004; no. 37: 1–2
• 16. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003; 58: 470–483
• 17. Torbicki A., Perrier A., Konstantinides S. i wsp. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the Euro-pean Society of Cardiology (ESC). Eur. Heart J. 2008; 29: 2276–2315.
• 18. Turkstra F., Kuijer P.M., van Beek E.J. i wsp. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann. Intern. Med. 1997; 126: 775–781.
• 19. Jardin F., Dubourg O., Bourdarias J.P. Echocardiographic pattern of acute cor pulmonale. Chest 1997; 111: 209–217
• 20. Davies H.E., Wathen C.G. & Gleeson F.V. The risks of radiation exposure related to diagnostic imaging and how to minimize them. BMJ 2011; 342: d947.
• 21. Winer-Muram H.T., Boone J.M., Brown H.L. i wsp. Pulmonary embo-lism in pregnant patients: fetal radiation dose with helical CT. Radiology 2002; 224: 487–492.
• 22. Einstein A.J., Henzlova M.J., Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA 2007; 298: 317–323.
• 23. Parker M.S., Hui F.K., Camacho M.A. i wsp. Female breast radiation exposure during CT pulmonary angiography. Am. J. Roentgenol. 2005; 185: 1228–1233.
• 24. Anderson D.R., Kahn S.R., Rodger M.A. i wsp. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial. JAMA 2007; 298: 2743–2753
• 25. Hurwitz L.M., Yoshizumi T.T., Reiman R.E. i wsp. Radiation dose to the female breast from 16-MDCT body protocols. Am. J. Roentgenol. 2006; 186: 1718–1722.
• 26. Marik P., Plante L. Venous thromboembolic disease and pregnancy. N. Engl. J. Med. 2008; 359: 2025–2033
• 27. Vahanian A., Baumgartner H., Bax J. i wsp. Guidelines on the manage-ment of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J. 2007; 28: 230–268.
• 28. Bates S., Greer I, Pabinger I. i wsp. Venous thromboembolism, throm-bophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 844S–886S.
• 29. Casele H., Laifer S., Woelkers D. i wsp. Changes in the pharmacokinetics of the low-molecular weight heparin enoxaparin sodium during pregnancy. Am. J. Obstet. Gynecol. 1999; 181: 1113–1117.
• 30. Baglin T., Brush J., Streiff M. Guidelines on use of vena cava filters. Br. J. Haematol. 2006; 134: 590–595.
• 31. Royal College of Obstetrics and Gynecology. Reducing the risk of thrombosis and embolism during pregnancy and puerperium. Green-top Guideline 2009; 37: 20–21.
• 32. Leonhardt G., Gaul C., Nietsch H. i wsp. Thrombolytic therapy in pregnancy. J. Thromb. Throm. 2006; 21: 271–276.
• 33. Ahearn G.S., Hadjiliadis D., Govert J.A. i wsp. Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: acase report and review of treatment options. Arch. Intern. Med. 2002; 162:1221–1227.
• 34. Leonhardt G., Gaul C., Nietsch H.H. i wsp. Thrombolytic therapy in pregnancy. J. Thromb. Thromb. 2006; 21: 271–276.
• 35. Hurwitz L.M., Yoshizumi T., Reiman R.E. i wsp. Radiation dose to the fetus from body MDCT during early gestation. Am. J. Roentgenol. 2006; 186: 871–876.
• 36. Winer-Muram H.T., Boone J.M., Brown H.L., Jennings S.G., Mabie W.C., Lombardo G.T. Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT. Radiology 2002; 224: 487–492.
• 37. Hurvitz L.M., Yoshizumi T.T., Reiman R.E. i wsp. Radiation dose to the female bret from 16-MDCT body protocols. Am. J. Roentgenol. 2006; 186: 1718–1722.

• Document Type: article